Educational corner

The role of therapeutic apheresis in the management of IBD

The primary goal when treating ulcerative colitis is to help patients regulate their immune systems better. However, current approved treatments do not work for all patients or do not control the disease all the time.

Several studies have suggested that GMA may be effective and safe in patients with IBD, especially in mild to moderate chronically active UC. It is especially useful in patients who do not respond to or are dependent on corticosteroids, because GMA can help reduce or withdraw them. GMA is also effective after loss of response to immunosuppressants or biologics and to replace toxic drug treatments. In addition, no adverse or very minor events have been reported.

This high-level medical e-learning webinar featuring leading Italian experts in IBD management will discuss and share experiences and opinions on GMA in IBD patients, as well as review existing evidence supporting its use.

February 6, 2023

The main objectives of this webinar are: clarify what is needed to have the best treatment outcome for IBD patients, how to help them maintain control of their disease and how Adacolumn’s mechanism of action might contribute to achieving both, alone or in combination with other therapies.

Dr. Alessandro Mazzoni. (A.O.U. Pisana)

Dra. Irene Bianco. (A.O.U. Pisana)

Dr. Eduardo V. Savarino (University of Padova, UNIPD · Department of Surgery, Oncology and Gastroenterology DISCOG)

Dr. Alessandro Mazzoni, Dra. Irene Bianco, Dr. Eduardo V. Savarino, Dr. Ambrosio Orlando & Dr. Rodolfo Sacco (Azienda Ospedaliero-Universitaria Policlinico Ospedali Riuniti Foggia · Gastroenterology and Digestive Endoscopy Unit)

Contact UsFor more information

Contact Us